Loading...
FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy
While 5-fluorouracil used as single agent in patients with metastatic colorectal cancer has an objective response rate around 20%, the administration of combinations of irinotecan with 5-fluorouracil/folinic acid or oxaliplatin with 5-fluorouracil/folinic acid results in significantly increased resp...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4130839/ https://ncbi.nlm.nih.gov/pubmed/25132748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i30.10316 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|